Contact this trialFirst, we need to learn more about you.
CDK 2 Inhibitor
ARTS-021 for Advanced Cancer
Recruiting1 awardPhase 1 & 2
Oklahoma City, Oklahoma
This trial tests a new oral medication, ARTS-021, to see if it's safe and can help treat advanced solid tumors. It may inhibit a protein called CDK 2.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.